Skip to content

Clinical Observation on the Prevention of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study

Clinical Observation on the Prevention of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126441
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic stem cell transplantation (HSCT)

Interventions

Multidimensional Comprehensive Management Group:None
Conventional management group:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing allogeneic hematopoietic stem cell transplantation; 2.A myeloablative conditioning regimen of standard dose was used; 3.Patients without pre-existing oral infections, ulcers, or other oral diseases prior to the start of conditioning; 4.Aged 10–70 years.

Exclusion criteria

Exclusion criteria: 1.ndividuals who failed to complete transplantation and thus could not be assessed for outcome endpoints; 2.Patients who had already developed oral infections, ulcers, or other oral diseases before the start of conditioning; 3.Patients with pre-transplant active herpesvirus infection.

Design outcomes

Primary

MeasureTime frame
The occurrence/development of oral mucositis;

Secondary

MeasureTime frame
Oral Pain Classification;Neutrophil Implantation Assessment;

Countries

China

Contacts

Public ContactWei Ling

The First Affiliated Hospital of Army Medical University

493143828@qq.com+86 23 68765407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026